Carrie Williams, Pmp
About Carrie Williams, Pmp
Carrie Williams is the Director of Cell Therapy Operations Portfolio & Project Management at Bristol Myers Squibb in Summit, New Jersey.
Company
Carrie Williams is currently employed at Bristol Myers Squibb. She holds the position of Director, Cell Therapy Operations Portfolio & Project Management. She operates in a hybrid work setup based in Summit, New Jersey, United States.
Title
Carrie Williams holds the title of Director, Cell Therapy Operations Portfolio & Project Management at Bristol Myers Squibb. Prior to her current role, she served as the Associate Director, Cell Therapy Business Process Management Portfolio Manager from 2020 to 2022, also at Bristol Myers Squibb.
Education and Expertise
Carrie Williams has a strong academic background in Chemistry and Pharmaceutical Sciences. She earned a Bachelor's degree in Chemistry from Drew University, where she studied from 1999 to 2003. She later achieved a Master's degree in Chemistry and Pharmaceutical Science from Fairleigh Dickinson University, studying there from 2005 to 2009.
Professional Background
Carrie Williams has extensive experience in the pharmaceutical industry. She worked at Merck as a Scientist from 2003 to 2013, based in Summit, New Jersey. She then moved to Ferring Pharmaceuticals where she was a Senior Manager of Portfolio Management from 2013 to 2020. Prior to her current role, she served at Bristol Myers Squibb as an Associate Director. Early in her career, she worked as a Research Assistant at Drew University in 2002.
Achievements
In her professional career, Carrie Williams has led significant initiatives. She transitioned over 300 projects from siloed solutions into a single enterprise project management system and trained over 100 users to support the on-time go-live for the Cell Therapy Operations portfolio. She harmonized 7 PMO processes into a single workflow and reduced vector consumption, thereby increasing patient treatment capacity. She also created a Portfolio Review Forum that improved data quality and expedited governance decisions.